New perspectives for patients: National Strategy for Gene and Cell Therapies presented to the BMBF

Today, the Berlin Institute of Health at Charité (BIH) officially handed over the National Strategy for Gene and Cell Therapies to Federal Research Minister Bettina Stark-Watzinger (FDP). Some 150 experts from various stakeholder groups drew up the…

5 Min
More

Tacalyx extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs

BERLIN, Germany, June 11, 2024 – Tacalyx, a privately held biotech company focused on developing novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announces the extension of its seed financing to over €14 M. This extension…

3 Min
More

QS World University Rankings 2025: Freie Universität Berlin Places Fourth among German Universities

University ranks ninety-seventh in the world. According to this year’s QS World University Rankings, Freie Universität Berlin is among the top four universities in Germany. The rankings are published annually by higher education consulting firm…

1 Min
More

BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease cell therapy candidate bemdaneprocel

• Regenerative Medicine Advanced Therapy (RMAT) designation follows phase I clinical trial results demonstrating that bemdaneprocel is well tolerated with no major safety issues through 18 months

• Bemdaneprocel is the most clinically advanced…

7 Min
More

Genetic mosaicism more common than thought

Blood stem cells from healthy people carry major chromosomal alterations, a study in “Nature Genetics” by researchers at the Max Delbrück Center and the European Molecular Biology Laboratory finds. The discovery suggests that we are all genetic…

4 Min
More

Klosterfrau-Group Award for Research of Airway Diseases in Childhood 2025

Application starts on June 3, 2024 and ends on November 22, 2024

3 Min
More

The BARDA VITAL Prize (BVP) Challenge

Deadline: June 7, 2024

 

Join the BARDA VITAL Prize (BVP) Challenge for Breakthrough Vaccines and Therapeutics

 

1 Min
More

Eckert & Ziegler receives “Best Managed Companies Award”

Eckert & Ziegler SE (ISIN DE0005659700) was honored with the “Best Managed Companies Award” at an award ceremony in Frankfurt am Main on May 23, 2024. With this award, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung and the Federation of German…

1 Min
More

Captain T Cell secures seed financing round

Captain T Cell, a spin-off from the Max Delbrück Center, raised €8.5 million in startup funding. The startup focuses on developing T cells to target solid tumors. The funds are intended to move a new generation of T cell therapies towards the clinic.

3 Min
More

€700,000 boost for preeclampsia research

Preeclampsia is one of the most common pregnancy-related complications. Florian Herse of the Max Delbrück Center and Martin Gauster of the Medical University of Graz are studying the role that Hofbauer cells play in the disorder. They have been…

3 Min
More
Show more items